Bain Capital Public Equity Management as of June 30, 2017
Portfolio Holdings for Bain Capital Public Equity Management
Bain Capital Public Equity Management holds 52 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | 27.1 | $594M | 453k | 1310.19 | |
| Honeywell International (HON) | 6.9 | $151M | 1.1M | 133.29 | |
| Altaba | 6.5 | $142M | 2.6M | 54.48 | |
| Northrop Grumman Corporation (NOC) | 4.9 | $108M | 420k | 256.71 | |
| Pentair cs (PNR) | 4.0 | $88M | 1.3M | 66.54 | |
| Johnson Controls International Plc equity (JCI) | 3.5 | $76M | 1.8M | 43.36 | |
| Godaddy Inc cl a (GDDY) | 3.2 | $71M | 1.7M | 42.42 | |
| Ball Corporation (BALL) | 3.2 | $70M | 1.6M | 42.21 | |
| Jack in the Box (JACK) | 2.5 | $55M | 556k | 98.50 | |
| Facebook Inc cl a (META) | 2.5 | $55M | 362k | 150.98 | |
| Citrix Systems | 2.4 | $53M | 672k | 79.58 | |
| Nxp Semiconductors N V (NXPI) | 2.4 | $52M | 477k | 109.45 | |
| Bank of America Corporation (BAC) | 2.4 | $52M | 2.1M | 24.26 | |
| Quintiles Transnatio Hldgs I | 2.2 | $48M | 537k | 89.50 | |
| Novartis (NVS) | 2.1 | $46M | 549k | 83.47 | |
| Amdocs Ltd ord (DOX) | 2.1 | $45M | 702k | 64.46 | |
| Regenxbio Inc equity us cm (RGNX) | 1.6 | $35M | 1.8M | 19.75 | |
| Forest City Realty Trust Inc Class A | 1.6 | $35M | 1.4M | 24.17 | |
| Mulesoft Inc cl a | 1.5 | $33M | 1.3M | 24.94 | |
| Puma Biotechnology (PBYI) | 1.4 | $30M | 339k | 87.40 | |
| Dollar Tree (DLTR) | 1.3 | $28M | 400k | 69.92 | |
| Avexis | 1.2 | $26M | 319k | 82.16 | |
| Invesco (IVZ) | 1.1 | $25M | 709k | 35.19 | |
| Rockwell Collins | 1.1 | $24M | 228k | 105.08 | |
| Aetna | 1.0 | $23M | 148k | 151.83 | |
| E TRADE Financial Corporation | 1.0 | $22M | 579k | 38.03 | |
| Dollar General (DG) | 0.9 | $21M | 286k | 72.09 | |
| Radius Health | 0.9 | $21M | 457k | 45.23 | |
| Hilton Worldwide Holdings (HLT) | 0.7 | $16M | 262k | 61.85 | |
| Ultimate Software | 0.7 | $15M | 71k | 210.07 | |
| Clovis Oncology | 0.6 | $13M | 141k | 93.63 | |
| Cloudera | 0.6 | $13M | 887k | 14.78 | |
| Avis Budget (CAR) | 0.5 | $11M | 388k | 27.27 | |
| Voyager Therapeutics (VYGR) | 0.5 | $11M | 1.2M | 8.96 | |
| PowerShares QQQ Trust, Series 1 | 0.5 | $9.8M | 25k | 394.64 | |
| Anthem (ELV) | 0.4 | $9.5M | 50k | 188.13 | |
| Gilead Sciences (GILD) | 0.4 | $8.5M | 120k | 70.78 | |
| Affimed Therapeutics B V | 0.3 | $6.6M | 3.2M | 2.05 | |
| Alkermes (ALKS) | 0.3 | $6.3M | 109k | 57.97 | |
| ViaSat (VSAT) | 0.3 | $6.1M | 92k | 66.20 | |
| Galapagos Nv- (GLPG) | 0.2 | $5.4M | 71k | 76.52 | |
| Barracuda Networks | 0.2 | $5.1M | 223k | 23.06 | |
| Dynavax Technologies (DVAX) | 0.2 | $4.7M | 491k | 9.65 | |
| Epizyme | 0.2 | $4.3M | 287k | 15.10 | |
| Meridian Ban | 0.2 | $4.1M | 240k | 16.90 | |
| Dick's Sporting Goods (DKS) | 0.2 | $3.8M | 96k | 39.83 | |
| Immune Design | 0.2 | $3.8M | 389k | 9.75 | |
| AstraZeneca (AZN) | 0.1 | $2.9M | 20k | 145.00 | |
| iShares Russell 2000 Index (IWM) | 0.1 | $2.2M | 13k | 174.00 | |
| Tesaro | 0.1 | $2.0M | 15k | 139.86 | |
| Ardagh Group S A cl a | 0.1 | $1.6M | 70k | 22.61 | |
| Proteostasis Therapeutics In | 0.1 | $1.2M | 264k | 4.68 |
